This videotape presents a comedic skit that illustrates the complexities involving care of a difficult inmate who has active TB disease and the collaboration needed to identify contacts and treat the inmate to cure. The videotape addresses transmission and infectiousness, medication regimen, length of treatment, and the need for good specimen collection and types of specimens.
Favorite
Correctional Facility Staff
2002
This report discusses the global efforts of national education and advocacy events that occurred on World Tuberculosis (TB) Day 2002. The report provides information about campaigns that promoted TB prevention through socioeconomic change, government support, the formation of partnerships between governments and nongovernmental organizations (NGOs), and improved healthcare access and delivery.
Favorite
International Agencies
2002
Explains Cure-TB, a referral program for people with TB moving between the United States and Mexico.
Favorite
Social Service Providers
2002
This booklet answers questions about the 4-drug fixed-dose combinations containing 150 mg rifampicin, 75 mg isoniazid, 400 mg pyrazinamide, and 275 mg ethambutol that were added to the WHO Model List of Essential Drugs for the treatment of TB.
Favorite
International Agencies
2002
This group of four fact sheets explain the origin and purpose of the Global Drug Facility (GDF), how the GDF works, how to apply to the GDF for a grant of TB drugs, and how to buy drugs through the GDF.
Favorite
International Agencies
2002
This report explains the European DOTS Expansion plan to control TB. The plan highlights country needs and resource gaps, emphasizing collaboration with the governments of endemic countries, national and international agencies, and nongovernmental organizations (NGOs). The aim is to stimulate social and political commitment to achieving the global TB targets as part of the overall health system...
Favorite
International Agencies
Policy Makers
2002
This report summarizes data from the national TB surveillance system for 2000 and compares them with data from 1992 to 1999.
Favorite
2002
This report discusses the burdens of AIDS, malaria, and TB; assesses the tools used to fight them; identifies barriers to success; and provides statistics on deaths caused by these diseases in 2000.
Favorite
International Agencies
Managers and Supervisors
2002
This document reinforces the five essential elements of the DOTS strategy.
Favorite
International Agencies
2002
This book presents five papers that were used as background to a workshop on "Improving TB Drug Management: Accelerating DOTS Expansion" on June 2002, in Washington, DC. The papers address the weaknesses in drug management programs of certain countries and provide a framework for strengthening these programs through country-specific action plans.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2002
This pamphlet discusses taking TB medicines, explains directly observed therapy, and the importance of taking all medications for the prescribed period of time.
Favorite
2002
This pamphlet uses a question and answer format to provide information on TB infection, how it is transmitted and diagnosed, what to do when a skin test is positive, and what a person needs to know about TB medicines.
Favorite
Persons With LTBI
2002
This pamphlet uses a question and answer format to provide information about coinfection with tuberculosis (TB) and the human immunodeficiency virus (HIV).
Favorite
Persons With LTBI
2002
This report summarizes the accomplishments and activities of the Stop TB Partnership in 2001.
Favorite
Community Leaders
2002
This report sets out the rationale for the ProTest Initiative (Promotion of Voluntary Testing), based on an analysis of the impact of HIV on TB control. It describes the elements of the ProTest approach, reviews progress so far, and sets out the future direction. The purpose of the report is to generate discussion and ideas that will help the Initiative establish a comprehensive range of interventions needed to control TB in settings with high prevalence of HIV infection.
Favorite
Policy Makers
2002
This book describes the technical framework and principles used to implement DOTS-Plus in resource poor settings. It also provides a number of case histories that illustrate common challenges in the treatment of MDR TB patients. The book includes protocols that can be used under DOTS-Plus program conditions to manage common complication of this therapy.
Favorite
2002
This brochure discusses TB and its relationship to HIV/AIDS.
Favorite
2002
This book discusses targeted tuberculin skin testing for latent TB infection as a strategic component of TB control. Specifically addressed are how to administer, read, and interpret the tuberculin skin test and its specificity and sensitivity.
Favorite
2002
This report, based upon current available scientific knowledge and medical practice, provides information to the medical community concerned with the care of individuals with tuberculosis and/or HIV/AIDS.
Favorite
2002
This fact sheet discusses the correlation between TB and poverty. It lists the steps in fighting TB and poverty, and states that DOTS is a global strategy to fight TB and alleviate poverty and inequity.
Favorite
2002
